[The sedative and amnesic effects of flunitrazepam during regional anaesthesia (author's transl)].
The sedative, hypnotic and amnesic effects of flunitrazepam, a new benzodiazepine, were tested in doses of 0 (placebo), 0,4 mg and 0,8 mg. These doses were sufficient to produce a satisfying sedative effect on patients, being operated on in regional anaesthesia. In few cases we found undesirable effects. Positive and negative aspects of amnesia will be discussed.
D000328:Adult; D000368:Aged; D000428:Alcohol Drinking; D000647:Amnesia / Q000139:chemically induced*; D000765:Anesthesia, Conduction; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D005260:Female; D005445:Flunitrazepam / Q000494:pharmacology*; D006801:Humans; D006993:Hypnotics and Sedatives; D008297:Male; D008875:Middle Aged
D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D005445:Flunitrazepam
Rohypnol (Flunitrazepam) als Sedativum bei Leitungsanästhesien unter besonderer Berücksichtigung der amnestischen Wirkung.